This article explores the potential of mesenchymal stem cell therapy for treating inflammatory bowel disease (IBD), focusing on ulcerative colitis. It discusses recent clinical trials and studies on the effectiveness and safety of this emerging treatment option and the advantages and disadvantages of using stem cells for treating IBD.
Menu
